科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究此手术的领域

医疗程序操作医生

编辑搜索过滤条件
Close

缩小搜索范围

  1. 查找姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 查找姓氏以该字母开头的医生 C
  4. 未找到姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 查找姓氏以该字母开头的医生 G
  8. 主动 查找姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 未找到姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 未找到姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 未找到姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤条件

显示 1-1 名医生(共 1 名医生)可选

姓氏首字母: H

  1. Mitchell R. Humphreys, M.D.

    Mitchell R. Humphreys, M.D.

    1. Urologist
    1. Phoenix, AZ
    擅长领域:

    HoLEP, Percutaneous nephrolithotomy, Minimally invasive surgery, Radical prostatectomy, Nephrectomy, Robotic prostatect...omy, Donor nephrectomy, Upper endoscopy, Benign prostatic hyperplasia, Prostate cancer, Kidney stone

研究

妙佑医疗国际的泌尿外科在肾脏疾病和需要手术切除肿瘤(肾切除术)的研究领域一直处于最前沿,无论是完全切除肾脏(根治性肾脏切除术)还是保留肾脏手术(部分肾切除术)

在最近一次对涉及 2200 多人的八项研究的回顾和分析中,妙佑医疗国际的研究人员发现,手术显著提高了许多晚期肾癌患者的预期寿命。与未做手术的继发性肿瘤(称为转移)患者相比,通过手术完全切除了继发性肿瘤的肾细胞癌患者的生存率明显提高。

这项研究证实在可能的情况下完全切除转移灶对延长生命的重要性。妙佑医疗国际的另一项研究将评估手术和药物的相互作用,以确定二者联合治疗是否能进一步提高晚期肾癌患者(癌细胞已扩散)的生存率。

妙佑医疗国际的研究工作继续着眼于新颖的手术技术和非手术选择上,以改善治疗效果,增加癌症治愈率并改善生活质量。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在肾脏切除术或部分肾切除术领域的文献著述列表

Research Profiles

在 Mayo Clinic 治疗

Jan. 13, 2022
  1. Nephrectomy. National Kidney Foundation. https://www.kidney.org/atoz/content/nephrectomy. Accessed March 15, 2017.
  2. Leibovich BC (expert opinion). Mayo Clinic, Rochester, Minn. March 8, 2017.
  3. Renal cell carcinoma. Merck Manual Professional Version. http://www.merckmanuals.com/professional/genitourinary-disorders/genitourinary-cancer/renal-cell-carcinoma. Accessed March 16, 2017.
  4. AskMayoExpert. Wilms tumor. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  5. AskMayoExpert. Partial nephrectomy. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  6. Richie JP. Definitive surgical management of renal cell carcinoma. https://www.uptodate.com/home. Accessed March 16, 2017.
  7. Richie JP, et al. Role of surgery in patients with metastatic renal cell carcinoma. https://www.uptodate.com/home. Accessed March 16, 2017.
  8. Tan HJ, et al. Long-term survival following partial vs. radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;307:1629.
  9. Abaza R, et al. Multi-institutional experience with robotic nephrectomy with inferior vena cava tumor thrombectomy. The Journal of Urology. 2016;195:865.
  10. Stewart-Merrill SB, et al. Oncologic surveillance after surgical resection for renal cell carcinoma: A novel risk-based approach. Journal of Clinical Oncology. 2015;33:4151.
  11. Kim SP, et al. Approach to the small renal mass: To treat or not to treat. Urologic Clinics of North America. 2012;39:171.
  12. Patton MW, et al. Robot-assisted partial nephrectomy for complex renal masses. Journal of Robotic Surgery. 2016;10:27.
  13. Zaid HB, et al. Outcomes following complete surgical metastasectomy for patients with metastatic renal cell carcinoma: A systematic review and meta-analysis. The Journal of Urology. 2017;197:44.
  14. Your kidneys and how they work. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/kidney-disease/kidneys-how-they-work. Accessed May 10, 2017.
  15. Solitary kidney. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/kidney-disease/solitary-kidney. Accessed May 10, 2017.

肾脏切除术(肾脏切除)